52 related articles for article (PubMed ID: 34480452)
1. [Rethymectomy in patients with myasthenia gravis and recurrent thymoma].
Pikin OV; Ryabov AB; Shcherbakova NI; Glushko VA; Kolbanov KI; Barmin VV; Aleksandrov OA; Bagrov VA; Khrushcheva NA; Salimov ZM; Martynova DE
Khirurgiia (Mosk); 2021; (9):27-33. PubMed ID: 34480452
[TBL] [Abstract][Full Text] [Related]
2. Thymectomy and Risk of Generalization in Patients with Ocular Myasthenia Gravis: A Multicenter Retrospective Cohort Study.
Li H; Ruan Z; Gao F; Zhou H; Guo R; Sun C; Xu Q; Lu Q; Zhou Y; Zhao Z; Yu L; Wu S; Lei T; Gao T; Tang Y; Li C; Huo F; Zhu Y; Sun J; Tang B; Zhang M; Gao Y; Lu X; Li Z; Chang T
Neurotherapeutics; 2021 Oct; 18(4):2449-2457. PubMed ID: 34625864
[TBL] [Abstract][Full Text] [Related]
3. Commentary: Progressive Encephalomyelitis with Rigidity and Myoclonus and Myasthenia Gravis Comorbid Status with Thymoma.
Balint B; Ogawa T; Ogaki K; Daida K; Nishimaki T; Ando M; Kawajiri S; Wada R; Noda K; Hattori N; Okuma Y; Barsottini O
Mov Disord Clin Pract; 2021 Aug; 8(Suppl 1):S14-S15. PubMed ID: 34514037
[No Abstract] [Full Text] [Related]
4. A case of myasthenia gravis showing recurrent monocular paralytic manifestations.
Behrman S
Proc R Soc Med; 1945 Oct; 38(12):664-5. PubMed ID: 19993175
[No Abstract] [Full Text] [Related]
5. GTF2I Mutation in Thymomas: Independence From Racial-Ethnic Backgrounds. An Indian/German Comparative Study.
Jain D; Guleria P; Singh V; Parshad R; Kumar S; Gaiser T; Kurz KS; Ott G; Porubsky S; Preissler G; Sauer CG; Schölch S; Ströbel P; Hielscher T; Marx A; Popovic ZV
Pathol Oncol Res; 2021; 27():1609858. PubMed ID: 34497477
[TBL] [Abstract][Full Text] [Related]
6. Neurological disorders associated with immune checkpoint inhibitors: an association with autoantibodies.
Seki M; Kitano S; Suzuki S
Cancer Immunol Immunother; 2022 Apr; 71(4):769-775. PubMed ID: 34515815
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome in patients with myasthenia gravis: one decade longitudinal study.
Bozovic I; Ilic Zivojinovic J; Peric S; Kostic M; Ivanovic V; Lavrnic D; Basta I
J Neurol; 2022 Apr; 269(4):2039-2045. PubMed ID: 34480608
[TBL] [Abstract][Full Text] [Related]
8. Anti-SOX1 Antibody-Positive Paraneoplastic Syndrome Presenting with Subacute Cerebellar Degeneration and Lambert-Eaton Myasthenic Syndrome: A Case Report.
Cheng YC; Chang A; Hsu WC
Acta Neurol Taiwan; 2021 Jun; 30(2)():74-77. PubMed ID: 34549392
[TBL] [Abstract][Full Text] [Related]
9. Elevated N-Linked Glycosylation of IgG V Regions in Myasthenia Gravis Disease Subtypes.
Mandel-Brehm C; Fichtner ML; Jiang R; Winton VJ; Vazquez SE; Pham MC; Hoehn KB; Kelleher NL; Nowak RJ; Kleinstein SH; Wilson MR; DeRisi JL; O'Connor KC
J Immunol; 2021 Oct; 207(8):2005-2014. PubMed ID: 34544801
[TBL] [Abstract][Full Text] [Related]
10. The impact of myasthenia gravis on lower urinary tract functions.
Akan O; Polat EC; Çulha MG; Önol SD
Int J Clin Pract; 2021 Dec; 75(12):e14873. PubMed ID: 34525243
[TBL] [Abstract][Full Text] [Related]
11. Changes in Physical Fitness and Body Composition Associated with Physical Exercise in Patients with Myasthenia Gravis: A Longitudinal Prospective Study.
Chang CC; Chen YK; Chiu HC; Yeh JH
J Clin Med; 2021 Sep; 10(17):. PubMed ID: 34501479
[TBL] [Abstract][Full Text] [Related]
12. IgG regulation through FcRn blocking: A novel mechanism for the treatment of myasthenia gravis.
Wolfe GI; Ward ES; de Haard H; Ulrichts P; Mozaffar T; Pasnoor M; Vidarsson G
J Neurol Sci; 2021 Nov; 430():118074. PubMed ID: 34563918
[TBL] [Abstract][Full Text] [Related]
13. Intrathymic Plasmablasts Are Affected in Patients With Myasthenia Gravis With Active Disease.
Yamamoto Y; Matsui N; Uzawa A; Ozawa Y; Kanai T; Oda F; Kondo H; Ohigashi I; Takizawa H; Kondo K; Sugano M; Kitaichi T; Hata H; Kaji R; Kuwabara S; Yamamura T; Izumi Y
Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34561276
[TBL] [Abstract][Full Text] [Related]
14. Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer.
Zubiri L; Molina GE; Mooradian MJ; Cohen J; Durbin SM; Petrillo L; Boland GM; Juric D; Dougan M; Thomas MF; Faje AT; Rengarajan M; Guidon AC; Chen ST; Okin D; Medoff BD; Nasrallah M; Kohler MJ; Schoenfeld SR; Karp-Leaf RS; Sise ME; Neilan TG; Zlotoff DA; Farmer JR; Bardia A; Sullivan RJ; Blum SM; Semenov YR; Villani AC; Reynolds KL
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34544895
[TBL] [Abstract][Full Text] [Related]
15. Charcot-Marie-Tooth disease type 4C associated with myasthenia gravis: coincidental or a foreseeable association?
Lorenzoni PJ; Kay CSK; Ducci RD; Fustes OJH; Werneck LC; Scola RH
Neurol Sci; 2022 Jan; 43(1):705-707. PubMed ID: 34532771
[TBL] [Abstract][Full Text] [Related]
16. Progressive Encephalomyelitis with Rigidity and Myoclonus and Myasthenia Gravis Comorbid Status with Thymoma.
Ogawa T; Ogaki K; Daida K; Nishimaki T; Ando M; Kawajiri S; Wada R; Noda K; Hattori N; Okuma Y
Mov Disord Clin Pract; 2021 Aug; 8(Suppl 1):S11-S13. PubMed ID: 34514036
[No Abstract] [Full Text] [Related]
17. Zytux in Refractory Myasthenia Gravis: A Multicenter, Open-Labeled, Clinical Trial Study of Effectiveness and Safety of a Rituximab Biosimilar.
Fatehi F; Moradi K; Okhovat AA; Shojatalab G; Sedighi B; Boostani R; Sarraf P; Haghi Ashtiani B; Ghasemi M; Moussavi S; Anjidani N; Nafissi S
Front Neurol; 2021; 12():682622. PubMed ID: 34512504
[No Abstract] [Full Text] [Related]
18. NKT and NKT-like Cells in Autoimmune Neuroinflammatory Diseases-Multiple Sclerosis, Myasthenia Gravis and Guillain-Barre Syndrome.
Zarobkiewicz MK; Morawska I; Michalski A; Roliński J; Bojarska-Junak A
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502425
[TBL] [Abstract][Full Text] [Related]
19. Laboratory Investigation of Hybrid IgG4 k/λ in MuSK Positive Myasthenia Gravis.
Basile U; Napodano C; Gulli F; Pocino K; Di Santo R; Todi L; Basile V; Provenzano C; Ciasca G; Marino M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502051
[TBL] [Abstract][Full Text] [Related]
20. Case Report: The Neuromusclar Triad of Immune Checkpoint Inhibitors: A Case Report of Myositis, Myocarditis, and Myasthenia Gravis Overlap Following Toripalimab Treatment.
Luo YB; Tang W; Zeng Q; Duan W; Li S; Yang X; Bi F
Front Cardiovasc Med; 2021; 8():714460. PubMed ID: 34485412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
